Pathogenic large rearrangements were also analyzed in 20,000 ovarian tumors with NGS and were detected in 0.7% of the cases, which reflected a total of 6.3% of all BRCA1/2 TPVs detected in the cohort [26]. This evidence concerns the gene BRCA1 and ovarian neoplasm.